MarketInOut Stock Screener Log In | Sign Up

Akeso Inc

HKSE • Healthcare • Biotechnology • Quote as of 10/28/2026 16:08
Akeso Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeHKSE
Market Capitalization79,771 mln
Float717 mln
Earnings Date03/31/2027

Piotroski F-Score

2 / 9
Weak

Beneish M-Score

-1.65
Likely manipulated

1-Year Forecast

154.10
Transformational upside

Relative Strength

7 / 100
Severely lagging

Debt / Equity

0.59
Moderate leverage

Pre-Tax Margin

-22%
Deeply loss-making

Business Description

Akeso Inc. is a China-based biopharmaceutical company that discovers, develops, and sells antibody-based medicines around the world. Its pipeline covers a wide range of serious conditions, including multiple forms of cancer such as lung, cervical, gastric, and liver cancer, as well as inflammatory diseases like psoriasis, atopic dermatitis, and ulcerative colitis. The company works across the full development cycle, from early research through to manufacturing and bringing treatments to market.

Key Fundamentals

EPS-1.21
ROE-8.93
RPS4.35
ROIC-13.04
ROA-4.71
Interest Cover-5.89
EBITDA, mln-352
EV / EBITDA-177
EV / EBIT-138
Revenue, mln3,859
EV / Revenue24.63

Quote Details

Last 85.05
Change 4.2 (5.19%)
Open 82.60
Volume 10,567,722
Turnover 898,784,768
Average Volume 11,503,357

Financial Ratios

Pre-Tax Profit Margin-22
Leverage Ratio1.91
Current Ratio4.01
Price / Book10.33
Price / Tangible Book10.35
Debt / Equity0.59
Price / Sales25.77

Financial Strength

Altman Z-Score8.08
Piotroski F-Score 2 / 9
Beneish M-Score-1.65
1-Year Target Price154.10

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -8.35% 14 / 100   
1 Month -9.09% 39 / 100   
2 Months -14% 39 / 100   
6 Months -38.06% 22 / 100   
1 Year -30.63% 38 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog